COVID-19 vaccines are effective against severe cases of the disease in children and adolescents, according to a review.
AUR-105 by Aurigene Oncology for Leukemia: Likelihood of Approval
AUR-105 is under clinical development by Aurigene Oncology and currently in Phase I for Leukemia.